Skip to main content
Image
BMVision detects lesions across the whole body

Better Medicine is an Estonian medical technology company founded in 2020 that focuses on applying artificial intelligence in radiology to detect oncological findings. Unlike traditional single-organ AI solutions, Better Medicine adopts a holistic, multi-organ approach, streamlining cancer diagnostics to aid in detecting primary tumours, metastases, and unidentified disease. The company's mission is to transform the landscape of cancer diagnostics and radiology, reducing the burden on professionals and improving outcomes of cancer patients.

Technical/scientific Challenge:

Better Medicine faces the challenge of efficiently training advanced AI models for lesion detection, measurement, and segmentation from CT scans. This requires substantial computational power to handle large datasets, optimize model performance, and reduce training time.

Solution:

Using the HPC Centre at the University of Tartu, Better Medicine leverages high-performance GPUs enabled nodes and scalable infrastructure to train deep learning models on large imaging datasets. The computational resources enable faster experimentation, precise parameter optimization, and the development of robust AI models ready for clinical use.

Business impact:

HPC resources significantly enhance the speed and accuracy of Better Medicine’s AI models, enabling rapid iteration cycles and model improvements. These models accelerate radiological workflows by automating lesion segmentation and measurement, addressing the global radiologist shortage, and expediting patient care. The adoption of HPC supports scalability, ensuring efficient handling of increasing data volumes as Better Medicine expands its solutions to broader clinical applications.

Benefits:

  • Reduced model training time from weeks to days

  • Improved AI model performance via rapid iteration cycles

  • Enhanced scalability for future clinical datasets

  • Enabling accelerated patient care through automated workflows